phrykt

ENvue Medical, Inc. (FEED): who owns it and who trades it

As of Oct 30, 2026, FEED insiders reported 17 open-market sales worth $151K and 1 purchase worth $641K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Christian Michael Glibert (Other), with $145K.

Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, FEED insiders reported $641K of open-market purchases and $151K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$641K
1 trades, 1 people
Sales, 12 months
$151K
17 trades, 2 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Jun 22, 2026
Filed Jun 22, 2026

Purchases and sales by month

$641K$641KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jun 22, 2026Christian Michael GlibertOtherSale210,000$0.69$145KForm 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale50$3.05$152Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale100$3.05$305Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale183$3.05$558Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale2$3.05$6Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale417$3.05$1.3KForm 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale98$3.05$299Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale82$3.05$250Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale100$3.06$306Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale100$3.07$307Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale90$3.05$274Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale10$3.05$30Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale18$3.05$55Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale500$3.05$1.5KForm 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale200$3.06$612Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale100$3.04$304Form 4
Feb 2, 2026Bank Of America Corp /De/ +210% ownerSale4$3.05$12Form 4
Jan 14, 2026Christian Michael Glibert10% ownerPurchase240,000$2.67$641KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Christian Michael Glibert10% owner$641K$145KJun 22, 2026
Bank Of America Corp /De/10% owner–$6.3KFeb 2, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

FEED short interest

Low short interest. 0.2% of FEED shares are sold short: about 1 share in 465. Over the last 12 reports the number of shares short went down 85%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 23,833 FEED shares were sold short, 0.2% of the shares outstanding, down 41.9% from the report before. At the average daily volume of 30,704 shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

0.22%May 15Oct 307.71%

Days to cover

1.0May 15Oct 301.7

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202623,8330.22%-42%30,7041.0
Oct 15, 202641,0080.37%+2%24,8471.6
Sep 30, 202640,0300.36%+149%53,2801.0
Sep 15, 202616,1070.15%-82%196,7001.0
Aug 31, 202687,7190.79%-75%212,8311.0
Aug 14, 2026344,0755.65%+359%3.04M1.0
Jul 31, 202674,9621.23%-54%202,9091.0
Jul 15, 2026161,6652.65%+166%507,4001.0
Jun 30, 202660,8391.00%-85%251,4161.0
Jun 15, 2026409,6836.73%+547%2.87M1.0
May 29, 202663,3421.04%-61%280,6331.0
May 15, 2026163,3914.41%+1388%982,7211.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

ENvue Medical company events

ENvue Medical filed 13 reports on Form 8-K in the last 12 months, 6 of them about an important change (leadership, listing). The latest was on Oct 14, 2026.

  1. Oct 14, 2026AgreementENvue Medical, Inc. entered into a Secured Promissory Note and Security Agreement with Alpha Capital Anstalt, pursuant to which the Lender agreed to provide the Company with financing in an of up to $1 million, to be funded in tranches agreed to between the Company and the Lender. Filing
  2. Aug 31, 2026AnnouncementThe Company issued a press release titled “ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split.” A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Filing
  3. Aug 14, 2026VoteReported shareholder vote results. Filing
  4. Aug 12, 2026AgreementENvue Medical, Inc. entered into a Common Shares Purchase Agreement, with an institutional investor, relating to a committed equity facility. Filing
  5. Jul 14, 2026LeadershipEach of David Johnson and Nino Pionati voluntarily resigned from their respective positions as members of the Board of Directors of ENvue Medical, Inc. Filing
  6. Jul 10, 2026ListingENvue Medical, Inc. received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that the Staff has determined that the closing bid price of the Company’s common stock, par value $0.001 per share, has been below $1.00 per share for the previous… Filing
  7. Feb 6, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Filing
  8. Jan 30, 2026AgreementAs previously disclosed in the Current Report on Form 8-K filed on July 22, 2025, in connection with the closing of the issuance and sale of the ENvue Medical,, Inc.’s Series H Convertible Preferred Stock, par value $0.001 per share on July 18, 2025, the Company filed a Certificate of Designation… Filing
  9. Dec 30, 2025LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Filing
  10. Dec 23, 2025LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Filing
  11. Dec 12, 2025RulesChanged its bylaws or articles. Filing
  12. Dec 5, 2025LeadershipAs previously disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on, on October 30, 2025, each of Christopher Fashek, Thomas Mika, Martin Goldstein, M.D. and Brian Murphy advised the Board of Directors of NanoVibronix, Inc. that they do not… Filing
  13. Nov 19, 2025AnnouncementShared information with investors. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

ENvue Medical financials

Questions about ENvue Medical, Inc. (FEED) stock

Are FEED insiders buying or selling?

In the last 12 months, FEED insiders reported 1 open-market purchase worth $641K and 17 sales worth $151K. The latest trade was on Jun 22, 2026. See every trade.

What is the short interest in FEED?

As of Oct 30, 2026, 23,833 FEED shares were sold short, 0.2% of the shares outstanding, down 41.9% from the report before. At the average daily volume of 30,704 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.